Jones Financial Companies’s Verona Pharma VRNA Stock Holding History

Jones Financial Companies’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-300	Closed	-$32K	–	4607
2025 Q3	$32K	Hold	300	–	–	﹤0.01%	2560
2025 Q2	$28.1K	Hold	300	–	–	﹤0.01%	2454
2025 Q1	$18.8K	Buy	300 +200	+200%	+$12K	﹤0.01%	2458
2024 Q4	$4.64K	Buy	+100	New	+$3.75K	﹤0.01%	2775

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Jones Financial Companies's VRNA Position: Q4 2025 in Review

Jones Financial Companies sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 300 shares — an estimated $32K sold.

Jones Financial Companies first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $32K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Jones Financial Companies reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Jones Financial Companies sold 300 Verona Pharma shares in Q4 2025, an estimated $32K.
Jones Financial Companies first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
Jones Financial Companies's Verona Pharma position peaked at $32K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Jones Financial Companies's 13F filing for Q4 2025, filed 17 Feb 2026.